One-Year Outcomes Using Ranibizumab for Neovascular Age-Related Macular Degeneration: Results of a Prospective and Retrospective Observational Multicentre Study

Hjelmqvist, Lars; Lindberg, Charlotte; Kanulf, Pär; Dahlgren, Henrik; Johansson, Ingrid; Siewert, Annica

doi:10.1155/2011/405724

Public

One-Year Outcomes Using Ranibizumab for Neovascular Age-Related Macular Degeneration: Results of a Prospective and Retrospective Observational Multicentre Study

Published in Journal of Ophthalmology • Jan 1, 2011

Authors:

Lars Hjelmqvist

Charlotte Lindberg

Pär Kanulf

Abstract

The Swedish Lucentis Quality Registry is a 12-month, open-label, observational, prospective, and retrospective study of ranibizumab administration for wet AMD. Visual acuity (VA) was measured with Snellen or ETDRS chart in 370 patients (66.8% women; age range 46-93 years). In total, a mean of 4.7 ± ...

Subject

Algorithm

Medicine

Artificial intelligence

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!